Mama's Creations (MAMA) 10-Q 13 Jun 16 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Apr. 30, 2016	Jun. 09, 2016
Document And Entity Information
Entity Registrant Name	MamaMancini's Holdings, Inc.
Entity Central Index Key	1,520,358
Document Type	10-Q
Document Period End Date	Apr. 30, 2016
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		27,349,568
Trading Symbol	MMMB
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,017

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Apr. 30, 2016	Jan. 31, 2016
Assets:
Cash	$ 502,459	$ 587,422
Accounts receivable, net	1,725,201	1,476,582
Inventories	506,985	252,752
Prepaid expenses	169,545	154,458
Due from manufacturer - related party	2,197,051	2,248,781
Total current assets	5,101,241	4,719,995
Property and equipment, net	989,402	1,047,455
Total Assets	6,090,643	5,767,450
Liabilities:
Accounts payable and accrued expenses	691,977	769,551
Line of credit, net	1,423,165	933,001
Term loan	120,000	120,000
Promissory notes	$ 240,761	266,808
Notes payable - related party		125,000
Convertible note payable, net	$ 2,540,000	2,540,000
Total current liabilities	5,015,903	4,754,360
Term loan - net of current	290,000	320,000
Promissory notes - net of current portion	16,324	$ 69,767
Notes payable - related party	125,000
Total long-term liabilities	431,324	$ 389,767
Total Liabilities	$ 5,447,227	$ 5,144,127
Stockholders' Equity
Preferred stock value
Common stock, $0.00001 par value; 250,000,000 shares authorized; 26,955,503 and 26,507,516 shares issued and outstanding, respectively	$ 270	$ 265
Additional paid in capital	15,265,644	14,954,928
Common stock subscribed, $0.00001 par value; 66,667 and 66,667 shares, respectively	1	1
Accumulated deficit	(14,472,999)	(14,182,371)
Less: Treasury stock, 230,000 and 230,000 shares, respectively	(149,500)	(149,500)
Total Stockholders' Equity	643,416	623,323
Total Liabilities and Stockholders' Equity	$ 6,090,643	$ 5,767,450
Series A Preferred Stock [Member]
Stockholders' Equity
Preferred stock value

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Apr. 30, 2016	Jan. 31, 2016
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	19,880,000	19,880,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	26,955,503	26,507,516
Common stock, shares outstanding	26,955,503	26,507,516
Common stock subscribed, par value	$ 0.00001	$ 0.00001
Common stock subscribed, shares	66,667	66,667
Treasury stock, shares	230,000	230,000
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	120,000	120,000
Preferred stock, shares issued	23,400	0
Preferred stock, shares outstanding	23,400	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Income Statement [Abstract]
Sales - net of slotting fees and discounts	$ 3,923,977	$ 3,236,490
Cost of sales	2,448,778	2,408,299
Gross profit	1,475,199	828,191
Operating expenses
Research and development	30,562	23,079
General and administrative expenses	1,499,857	1,657,759
Total operating expenses	1,530,419	1,680,838
Loss from operations	(55,220)	(852,647)
Other expenses
Interest expense	(161,762)	(123,357)
Amortization of debt discount	(9,125)	(118,552)
Total other expenses	(170,887)	(241,909)
Net loss	(226,107)	$ (1,094,556)
Less: preferred dividends	(64,521)
Net loss available to common stockholders	$ (290,628)	$ (1,094,556)
Net loss per common share - basic and diluted	$ (0.01)	$ (0.04)
Weighted average common shares outstanding - basic and diluted	26,507,516	26,057,141

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (226,107)	$ (1,094,556)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	76,703	67,200
Amortization of debt discount	9,125	118,552
Share-based compensation	179,208	2,042
(Increase) Decrease in:
Accounts receivable	(248,619)	967,934
Inventories	(254,233)	(168,175)
Prepaid expenses	(15,087)	(5,016)
Due from manufacturer - related party	51,730	7,621
Increase (Decrease) in:
Accounts payable and accrued expenses	(10,582)	(223,783)
Net Cash Used In Operating Activities	(437,862)	(336,755)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for fixed assets	(18,650)	(65,494)
Net Cash Used In Investing Activities	$ (18,650)	(65,494)
CASH FLOWS FROM FINANCING ACTIVITIES:
Deferred offering costs		(10,000)
Proceeds from demand notes		450,000
Borrowings (repayments) of line of credit, net	$ 481,039	(462,779)
Repayment of term loan	(30,000)	$ (30,000)
Repayment of promissory notes	(79,490)
Net Cash Provided By (Used in) Financing Activities	371,549	$ (52,779)
Net Decrease in Cash	(84,963)	(455,028)
Cash - Beginning of Period	587,422	854,995
Cash - End of Period	$ 502,459	$ 399,967
SUPPLEMENTARY CASH FLOW INFORMATION:
Income taxes
Interest	$ 72,311
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for debt discount on convertible note		$ 39,600
Accrued dividends	$ 64,521
Stock issued for Series A Preferred dividends	$ 131,513

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	3 Months Ended
	Apr. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Basis of Presentation	Note 1 - Nature of Operations and Basis of Presentation Nature of Operations MamaMancini’s Holdings, Inc. (the “Company”), (formerly known as Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation. The Company has a year-end of January 31. The Company is a manufacturer and distributor of beef meatballs with sauce, turkey meatballs with sauce, and other similar meats and sauces. The Company’s customers are located throughout the United States, with a large concentration in the Northeast and Southeast. Basis of Presentation The condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. The unaudited financial information furnished herein reflects all adjustments, consisting solely of normal recurring items, which in the opinion of management are necessary to fairly state the financial position of the Company and the results of its operations for the periods presented. This report should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year ended January 31, 2016 filed on April 21, 2016. The Company assumes that the users of the interim financial information herein have read or have access to the audited financial statements for the preceding fiscal year and that the adequacy of additional disclosure needed for a fair presentation may be determined in that context. The condensed consolidated balance sheet at January 31, 2016 was derived from audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. The results of operations for the interim periods presented are not necessarily indicative of results for the year ending January 31, 2017. The Company adopted Accounting Standards Update (“ASU”) 2015-03, “ Interest-Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company incurred a net loss available to common shareholders of $290,628 and $1,094,556 during the three months ended April 30, 2016 and 2015, respectively. Also, as of April 30, 2016, the Company had $502,459 in cash, and working capital of $85,338. These factors all raise substantial doubt about the ability of the Company to continue as a going concern. In their report for the fiscal year ended January 31, 2016, the Company’s auditors have expressed an opinion that, as a result of the conditions noted, there is substantial doubt regarding the ability to continue as a going concern. Management’s plans include raising additional funding from debt and/or equity transactions that will be used to refinance the Company’s maturing debt and for general working capital purposes. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2016
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for doubtful accounts, inventory obsolescence and the fair value of share-based payments. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates. Risks and Uncertainties The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure. The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis. Cash The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at April 30, 2016 or January 31, 2016. The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of April 30, 2016 and January 31, 2016, the Company had reserves of $2,000. Inventories Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at April 30, 2016 and January 31, 2016: April 30, 2016 January 31, 2016 Finished goods $ 506,985 $ 252,752 Property and Equipment Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives. Asset lives for financial statement reporting of depreciation are: Machinery and equipment 2-7 years Furniture and fixtures 3-5 years Leasehold improvements 3-10 years Fair Value of Financial Instruments For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short-term financial instruments approximates fair value due to the relatively short period to maturity for these instruments. Stock Issuance Costs Stock issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity and netted against proceeds. In the event the costs are in excess of the proceeds, the costs are recorded to expense. In the case of an aborted offering, all costs are expensed. Offering costs recorded to equity for the three months ended April 30, 2016 and 2015 were $0 and $0, respectively. Research and Development Research and development is expensed as incurred. Research and development expenses for the three months ended April 30, 2016 and 2015 were $30,562 and $23,079, respectively. Shipping and Handling Costs The Company classifies freight billed to customers as sales revenue and the related freight costs as general and administrative expenses. Revenue Recognition The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products. The Company meets these criteria upon shipment. Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows: Three Months Ended April 30, 2016 Three Months Ended April 30, 2015 Gross Sales $ 4,040,988 $ 3,428,864 Less: Slotting, Discounts, Allowances 117,011 192,374 Net Sales $ 3,923,977 $ 3,236,490 Cost of Sales Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs. Advertising Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the three months ended April 30, 2016 and 2015 were $420,892 and $800,143, respectively. Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “ Compensation – Stock Compensation” Equity Based Payments to Non-Employees The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the condensed consolidated statement of operations. Share-based payments issued to placement agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital. For the three months ended April 30, 2016 and 2015, share-based compensation amounted to $179,208 and $2,042, respectively. For the three months ended April 30, 2016, when computing fair value of share-based payments, the Company has considered the following variables: April 30, 2016 Risk-free interest rate 1.28% to 1.33 % Expected life of grants 2.5 years Expected volatility of underlying stock 178% to 179 % Dividends 0 % The expected option term is computed using the “simplified” method as permitted under the provisions of ASC 718-10-599. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. The expected stock price volatility for the Company’s stock options was determined by the historical volatilities for industry peers and used an average of those volatilities. Risk free interest rates were obtained from U.S. Treasury rates for the applicable periods. Earnings (Loss) Per Share Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. The Company had the following potential common stock equivalents at April 30, 2016: Series A Preferred 3,466,667 Common stock warrants, exercise price range of $0.675-$2.50 4,964,734 Common stock options, exercise price of $0.39-$2.97 758,404 Total common stock equivalents 9,189,805 The Company had the following potential common stock equivalents at April 30, 2015: Common stock warrants, exercise price range of $1.00-$2.50 1,004,735 Common stock options, exercise price of $1.00-$2.97 496,404 Total common stock equivalents 1,501,139 Since the Company reflected a net loss during the three months ended April 30, 2016 and 2015, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented. Income Taxes Income taxes are provided in accordance with ASC No. 740, “ Accounting for Income Taxes Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company is no longer subject to tax examinations by tax authorities for years prior to 2012. Reclassification Certain prior period amounts have been reclassified to conform to current period presentation. Recent Accounting Pronouncements In May 2014, the FASB issued a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The standard’s core principle (issued as ASU 2014-09 by the FASB), is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The new guidance must be adopted using either a full retrospective approach for all periods presented in the period of adoption or a modified retrospective approach. In August 2015, the FASB issued ASU No. 2015-14, which defers the effective date of ASU 2014-09 by one year, and would allow entities the option to early adopt the new revenue standard as of the original effective date. This ASU is effective for public reporting companies for interim and annual periods beginning after December 15, 2017. The Company is currently evaluating its adoption method and the impact of the standard on its condensed consolidated financial statements. In March 2015, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2015-03, “ Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs In July 2015, the FASB issued ASU No. 2015-11, “ Inventory (Topic 330): Simplifying the Measurement of Inventory” In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” In April 2016, the FASB issued ASU No. 2016-10, “ Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross verses Net)” In April 2016, the FASB issued ASU No. 2016-09, “ Compensation – Stock Compensation” Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements.

Property and Equipment

Property and Equipment	3 Months Ended
	Apr. 30, 2016
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 3 - Property and Equipment: Property and equipment on April 30, 2016 and January 31, 2016 are as follows: April 30, 2016 January 31, 2016 Machinery and Equipment $ 1,131,172 $ 1,112,522 Furniture and Fixtures 17,942 17,942 Leasehold Improvements 429,282 429,282 1,578,396 1,559,746 Less: Accumulated Depreciation 588,994 512,291 $ 989,402 $ 1,047,455 Depreciation expense charged to income for the three months ended April 30, 2016 and 2015 amounted to $76,703 and $67,200, respectively.

Investment in Meatball Obsessio

Investment in Meatball Obsession, LLC	3 Months Ended
	Apr. 30, 2016
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Investment in Meatball Obsession, LLC	Note 4 - Investment in Meatball Obsession, LLC During 2011 the Company acquired a 34.62% interest in Meatball Obsession, LLC (“MO”) for a total investment of $27,032. This investment is accounted for using the equity method of accounting. Accordingly, investments are recorded at acquisition cost plus the Company’s equity in the undistributed earnings or losses of the entity. At December 31, 2011 the investment was written down to $0 due to losses incurred by MO. The Company’s ownership interest in MO has decreased due to dilution. At April 30, 2016 and January 31, 2016, the Company’s ownership interest in MO was 12% and 12%, respectively.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Apr. 30, 2016
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 - Related Party Transactions Joseph Epstein Foods On March 1, 2010, the Company entered into a five year agreement with Joseph Epstein Foods (the “Manufacturer”) who is a related party. The Manufacturer is co-owned by the CEO and President of the Company. The Company analyzed the relationship with the Manufacturer to determine if the Manufacturer is a variable interest entity as defined by FASB ASC 810 “Consolidation”. Based on this analysis, the Company has determined that the Manufacturer is a variable interest entity but the Company is not the primary beneficiary of the variable interest entity and therefore consolidation is not required. In addition, based on the analysis the Company determined that the CEO and President of the Company is the primary beneficiary of the variable interest entity and bears the risk of loss. Under the terms of the agreement, the Company grants to the Manufacturer a revocable license to use the Company’s recipes, formulas, methods and ingredients for the preparation and production of Company’s products, for manufacturing the Company’s product and all future improvements, modifications, substitutions and replacements developed by the Company. The Manufacturer in turn grants the Company the exclusive right to purchase the product. Under the terms of the agreement the Manufacturer agrees to manufacture, package, and store the Company’s products and the Company has the right to purchase products from one or more other manufacturers, distributors or suppliers. The agreement contains a perpetual automatic renewal clause for a period of one year after the expiration of the initial term. During the renewal period either party may cancel the contract with written notice nine months prior to the termination date. Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the Manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the Manufacturer for any labor costs incurred in repackaging. Per the agreement, all product delivery shipping costs are the expense of the Company. The Company agreed with the Manufacturer at the end of the last fiscal year that Company would purchase a minimum of $933,000 of product each month and that any amount below that sum would be a charge of 12% of that shortfall each month. In return, the Manufacturer obligated itself to offer the Company competitive prices and would not co-pack for other suppliers and would either maintain or lower its payable to the Company each quarter. In addition, the Manufacturer agreed to rebate the Company any overage of gross margin above 12% each month. From time to time the Company will make improvements to the Manufacturer’s facility. The improvements are capitalized and depreciated over the estimated useful life. During the three months ended April 30, 2016 and 2015, the Company purchased inventory of $2,843,012 and $2,425,621, respectively, from the Manufacturer. During the three months ended April 30, 2016 and 2015, the Manufacturer incurred expenses of $6,000 and $6,000, respectively, on behalf of the Company for shared administrative expenses and salary expenses. At April 30, 2016 and January 31, 2016, the amount due from the Manufacturer is $2,197,051 and $2,248,781 respectively. Meatball Obsession, LLC A current director of the Company is the chairman of the board and shareholder of Meatball Obsession LLC (“MO”). For the three months ended April 30, 2016 and 2015, the Company generated approximately $10,102 and $25,408 in revenues from MO, respectively. As of April 30, 2016 and January 31, 2016, the Company had a receivable of $3,296 and $6,512 due from MO, respectively. WWS, Inc. A current director of the Company is the president of WWS, Inc. For the three months ended April 30, 2016 and 2015, the Company recorded $12,000 and $12,000 in commission expense from WWS, Inc. generated sales, respectively. Notes Payable During the year ended January 31, 2016, the Company received aggregate proceeds of $125,000 from notes payable with the CEO of the Company. The notes bear interest at a rate of 4% per annum and mature on December 31, 2016. During the quarter ended April 30, 2016, the notes were extended until February 2018. As of April 30, 2016, the outstanding principal balance of the notes was $125,000.

Promissory Notes

Promissory Notes	3 Months Ended
	Apr. 30, 2016
Debt Disclosure [Abstract]
Promissory Notes	Note 6 - Promissory Notes On October 31, 2015, the Company entered into a promissory note agreement with a third party to settle outstanding payables. The note is for a total principal balance of $358,832, bearing interest at a rate of 10% and maturing in October 2017. The Company is required to prepay the note 10% of the net proceeds received upon the closing of a capital raise, except for, those transactions conducted with the Company’s Chief Executive Officer. The Company paid $173,373 toward the outstanding balance, a portion of which is 10% of the net proceeds from the final closing of the private placement in November 2015. As of April 30, 2016 and January 31, 2016, the outstanding balance on the note was $191,082 and $239,459, respectively. In January 2016, the Company entered into a promissory note agreement with a third party to settle outstanding payables. The note is for a total principal balance of $116,003, bearing interest at a rate of 6% and maturing in October 2016. As of April 30, 2016 and January 31, 2016, the outstanding balance on the note was $66,003 and $97,116, respectively. As of April 30, 2016 and January 31, 2016, the aggregate outstanding balance on the notes was $257,085 and $336,575, respectively.

Loan and Security Agreement

Loan and Security Agreement	3 Months Ended
	Apr. 30, 2016
Debt Disclosure [Abstract]
Loan and Security Agreement	Note 7 - Loan and Security Agreement On September 3, 2014, the Company entered into a Loan and Security Agreement (“Loan and Security Agreement”) with Entrepreneur Growth Capital, LLC (“EGC”) which contains a line of credit. As of April 30, 2016 and January 31, 2016, the outstanding balance on the line of credit was $1,423,165 and $933,001, respectively, net of debt discount of $17,495 and $26,620, respectively. The total facility is for an aggregate principal amount of up to $3,100,000. The facility consists of the following: ● Accounts Revolving Line of Credit: $ 2,150,000 ● Inventory Revolving Line of Credit: $ 350,000 ● Term Loan: $ 600,000 EGC may from time to time make loans in an aggregate amount not to exceed the Accounts Revolving Line of Credit up to 85% of the net amount of Eligible Accounts (as defined in the Loan and Security Agreement). EGC may from time to time make loans in an aggregate amount not to exceed the Inventory Revolving Line of Credit against Eligible Inventory (as defined in the Loan and Security Agreement) in an amount up to 50% of finished goods and in an amount up to 20% of raw material. The revolving interest rates is equal to the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus (a) 2.5% on loans and advances made against eligible accounts and (b) 4.0% on loans made against eligible inventory. The term loan bears interest at a rate of the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0%. The initial term of the facility is for a period of two years and will automatically renew for an additional one year period. The Company was required to pay a one-time, up-front facility fee equal to 2.25% of the total $3,100,000 facility and pays an annualized maintenance fee equal to 3% of the total facility. In the event of default, the Company shall pay 10% above the stated rates of interest per the Agreement. The drawdowns are secured by all of the assets of the Company. During the first quarter of 2016, the Company adopted ASU 2015-03, “ Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs The debt discount will be amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt, using the straight-line method which approximates the effective interest method. The amortization of debt discount is included as a component of other expense in the condensed consolidated statements of operations. There was unamortized debt discount of $17,495 and $26,620 as of April 30, 2016 and January 31, 2016, respectively. As of April 30, 2016 and January 31, 2016 the outstanding balance on the line of credit was $1,423,165 and $933,001, respectively. On September 3, 2014, the Company also entered into a 5 year $600,000 Secured Promissory Note (“EGC Note”) with EGC. The EGC Note is payable in 60 monthly installments of $10,000. The EGC Note bears interest at the prime rate plus 4.0% and is payable monthly, in arrears. In the event of default, the Company shall pay 10% above the stated rates of interest per the Loan and Security Agreement. The EGC Note is secured by all of the assets of the Company. The outstanding balance on the term loan was $410,000 and $440,000 as of April 30, 2016 and January 31, 2016, respectively. Additionally, in connection with the Loan and Security Agreement, Carl Wolf, the Company’s Chief Executive Officer entered into a Guarantee Agreement with EGC, personally guaranteeing all the amounts borrowed on behalf of the Company under the Loan and Security Agreement.

Convertible Note

Convertible Note	3 Months Ended
	Apr. 30, 2016
Debt Disclosure [Abstract]
Convertible Note	Note 8 - Convertible Note On December 19, 2014, the Company entered into a securities purchase agreement (the “Manatuck Purchase Agreement”) with Manatuck Hill Partners, LLC (“Manatuck”) whereby the Company issued a convertible redeemable debenture (the “Manatuck Debenture”) in favor of Manatuck. The Manatuck Debenture is for $2,000,000 bearing interest at a rate of 14% and matures in February 2016. Upon issuance of the Manatuck Debenture, the Company granted Manatuck 200,000 shares of the Company’s restricted common stock. In April 2015, the maturity date was extended to May 2016 and 30,000 shares of restricted common stock were issued to Manatuck. Based on management’s review, the accounting for debt modification applied. The Company valued the 30,000 shares at the grant date share price of $1.32 and recorded $39,600 to debt discount on the condensed consolidated balance sheet. Upon issuance of the debenture and subsequent extension, a debt discount of $498,350 was recorded for the fees incurred by the buyer as well as the value of the common shares granted to Manatuck. The debt discount will be amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt, using the straight-line method which approximates the effective interest method. The amortization of debt discount is included as a component of other expense in the condensed consolidated statements of operations. There was unamortized debt discount of $0 and $0 as of April 30, 2016 and January 31, 2016, respectively. On October 29, 2015, the note was further amended to extend the maturity date to December 19, 2016. Per the terms of the execution of the extension, the Company was required to purchase the above 230,000 shares issued to Manatuck for a share price of $0.65, a value of $149,500 and incurred an amendment fee of $170,500, both of which were added to the outstanding principal of the debt. In addition, the extension reduced accrued interest by $220,000 and increased the outstanding principal of the debt by $220,000. Based on management’s review, the accounting for debt extinguishment applied. In accordance with the accounting for debt extinguishment, the Company wrote-off the existing debt of $2,000,000, wrote-off the unamortized debt discount of $190,483 and wrote-off the remaining debt issuance costs relating to this note of $19,106. The loss on debt extinguishment of $380,089 on the statement of operations is comprised of the write-off of the remaining debt discount of $190,483, the write-off of the debt issuance costs of $19,106, and the amendment fee of $170,500. The outstanding principal at April 30, 2016 and January 31, 2016 was $2,540,000. Optional conversion to convertible preferred stock is available upon completion of a qualified offering (as defined in the Manatuck Purchase Agreement) while the Manatuck Debenture is outstanding. Upon conversion of the Manatuck Debenture, the Company shall issue Manatuck shares of common stock as defined in the Manatuck Purchase Agreement. Future maturities of long-term debt are as follows: For the Twelve Month Period Ending April 30, 2017 $ 4,341,421 2018 261,324 2019 120,000 2020 50,000 $ 4,772,745

Concentrations

Concentrations	3 Months Ended
	Apr. 30, 2016
Risks and Uncertainties [Abstract]
Concentrations	Note 9 - Concentrations Revenues During the three months ended April 30, 2016, the Company earned revenues from four customers representing approximately 14%, 13%, 12% and 11% of gross sales. As of April 30, 2016, these customers represented approximately 16%, 8%, 14% and 25% of total gross outstanding receivables, respectively. During the three months ended April 30, 2015, the Company earned revenues from four customers representing approximately 20%, 16%, 15% and 11% of gross sales. As of April 30, 2015, these customers represented approximately 14%, 11%, 23%, and 7% of total gross outstanding receivables, respectively. Cost of Sales For the three months ended April 30, 2016 and 2015, one vendor (a related party) represented 98% and 95% of the Company’s purchases, respectively.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	3 Months Ended
	Apr. 30, 2016
Equity [Abstract]
Stockholders' Equity (Deficit)	Note 10 - Stockholders’ Equity (Deficit) (A) Series A Convertible Preferred Stock Transactions On May 28, 2015, the Company amended its articles of incorporation to establish the designation, powers, rights, privileges, preferences and restrictions of the Series A Convertible Preferred Stock (“Series A Preferred”). The Company authorized 120,000 shares of Series A Preferred with each share of our Series A Preferred having a par value of $0.00001 and stated value equal to $100, as adjusted for stock dividends, combinations, splits and certain other events. The Company analyzed the conversion feature for potential derivative classification. On May 28, 2015, the Company amended its articles of incorporation to establish the designation, powers, rights, privileges, preferences and restrictions of the Series A Convertible Preferred Stock (“Series A Preferred”). The Company authorized 120,000 shares of Series A Preferred with each share of our Series A Preferred having a par value of $0.00001 and stated value equal to $100 (“Stated Value”), as adjusted for stock dividends, combinations, splits and certain other events. The Company analyzed the conversion feature for potential derivative classification. Despite the ratchet features included in the conversion option, the Company concluded that equity treatment was warranted since the feature was clearly and closely related to the host contract. The holders of the Series Preferred A will be entitled to (a) dividends at a rate of 8% per annum, (b) a liquidation preference equal to $0.675 per Series A Preferred share, (c) the option to convert the Series A Preferred shares to a number of shares of common stock calculated by dividing the Stated Value by $0.675 and (d) warrants to purchase a number of common shares calculated by dividing the Stated Value by $0.675 exercisable for a period of five years at a price of $1.00 per share. There is also an automatic conversion based on the occurrence of certain events detailed in the Certificate of Designation. As of April 30, 2016, all accrued dividends had been paid in Company common stock. Additionally, in April 2016 the Company granted an aggregate of an additional 2,510,001 Warrants to investors in a prior offering. These Warrants are for a term of five (5) years at an exercise price of $1.50 per share. During May 2015, six directors of the Company entered into convertible note agreements with a maturity date of July 22, 2016 for total proceeds to the Company of $650,000. In June 2015, the notes were converted into Series A Preferred. Additional proceeds of $560,000 were received pursuant to closings that occurred in June, August and September. In connection with the closings, the Company also granted warrants to purchase 1,481,481 and 179,259 shares of common stock at $0.675 per share to shareholders and the placement agent, respectively. The warrants granted to the placement agent have a grant date fair value of $84,547 which is treated as a direct cost of the Financing and has been recorded as a reduction in additional paid in capital. During November 2015, the Company completed the final closing of a private placement with 11 accredited investors and issued an aggregate of 10,200 shares of Series A Preferred and warrants to purchase 1,511,112 shares of common stock for aggregate gross proceeds to the Company of $1,020,000. Stock issuance costs of $132,600 were paid to placement agents yielding net proceeds of $887,400. Of these issuance costs, approximately $86,000 were pursuant to the promissory note agreement as discussed in Note 6. As discussed in Note 6, during January 2016, the Company settled an outstanding payable with one of its vendors by issuing a promissory note in the principal amount of $116,003 and 1,100 shares of the Company’s Series A Preferred and warrants to purchase 162,963 shares of common stock. (B) Common Stock Transactions Common Stock During the three months ended April 30, 2016, the Company issued 268,395 shares of its common stock to the holders of the Series A Preferred stockholders for the dividends in arrears totaling $131,513. During the three months ended April 30, 2016, the Company issued 179,592 shares of its common stock to employees for services rendered a value of $92,000. Treasury Stock As discussed in Note 8, upon amendment of the Manatuck Debenture on October 29, 2015, the Company repurchased the 230,000 shares for an aggregate purchase price of $149,500 which is presented as Treasury Stock on the condensed consolidated balance sheets. (C) Options The following is a summary of the Company’s option activity: Options Weighted Average Exercise Price Outstanding – January 31, 2016 496,404 $ 1.04 Exercisable – January 31, 2016 496,404 $ 1.04 Granted 262,000 $ 0.40 Exercised - $ - Forfeited/Cancelled - $ - Outstanding – April 30, 2016 758,404 $ 0.81 Exercisable – April 30, 2016 758,404 $ 0.81 Options Outstanding Options Exercisable Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.39 – 2.97 758,404 2.69 years $ 0.81 758,404 $ 0.81 At April 30, 2016 and 2015, the total intrinsic value of options outstanding and exercisable was $25,000 and $87,733, respectively. (D) Warrants The following is a summary of the Company’s warrant activity: Warrants Weighted Average Exercise Price Outstanding – January 31, 2016 4,964,734 $ 0.80 Exercisable – January 31, 2016 4,964,734 $ 0.80 Granted - $ - Exercised - $ - Forfeited/Cancelled - $ - Outstanding – April 30, 2016 4,964,734 $ 0.80 Exercisable – April 30, 2016 4,964,734 $ 0.80 Warrants Outstanding Warrants Exercisable Range of Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.68-$2.50 4,964,734 3.86 years $ 0.80 4,964,734 $ 0.80 At April 30, 2016 and 2015, the total intrinsic value of warrants outstanding and exercisable was $0 and $88,925, respectively.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11 - Commitments and Contingencies Litigations, Claims and Assessments From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results. Licensing and Royalty Agreements On March 1, 2010, the Company was assigned a Development and License agreement (the “Agreement”). Under the terms of the Agreement the Licensor shall develop for the Company a line of beef meatballs with sauce, turkey meatballs with sauce and other similar meats and sauces for commercial manufacture, distribution and sale (each a “Licensor Product” and collectively the “Licensor Products”). Licensor shall work with Licensee to develop Licensor Products that are acceptable to Licensee. Upon acceptance of a Licensor Product by Licensee, Licensor’s trade secret recipes, formulas methods and ingredients for the preparation and production of such Licensor Products (the “Recipes”) shall be subject to this Development and License Agreement. The term of the Agreement (the “Term”) shall consist of the Exclusive Term and the Non-Exclusive Term. The 12-month period beginning on each January 1 and ending on each December 31 is referred to herein as an “Agreement Year”. The Exclusive Term began on January 1, 2009 (the “Effective Date”) and ends on the 50th anniversary of the Effective Date, unless terminated or extended as provided herein. Licensor, at its option, may terminate the Exclusive Term by notice in writing to Licensee, delivered between the 60th and the 90th day following the end of any Agreement Year if, on or before the 60th day following the end of such Agreement Year, Licensee has not paid Licensor Royalties with respect to such Agreement Year at least equal to the minimum royalty (the “Minimum Royalty”) for such Agreement Year. Subject to the foregoing sentence, and provided Licensee has not breached this Agreement and failed to cure such breach in accordance herewith, Licensee may extend the Exclusive Term for an additional twenty five (25) years, by notice in writing to Licensor, delivered on or before the 50th anniversary of the Effective Date. The Non-Exclusive Term begins upon expiration of the Exclusive Term and continues indefinitely thereafter, until terminated by Licensor due to a material breach hereof by Licensee that remains uncured after notice and opportunity to cure in accordance herewith, or until terminated by Licensee. Either party may terminate this Agreement in the event that the other party materially breaches its obligations and fails to cure such material breach within sixty (60) days following written notice from the non-breaching party specifying the nature of the breach. The following termination rights are in addition to the termination rights provided elsewhere in the agreement ● Termination by Licensee - Licensee shall have the right to terminate this Agreement at any time on sixty (60) days written notice to Licensor. In such event, all moneys paid to Licensor shall be deemed non-refundable. Under the terms of the Agreement the Company is required to pay quarterly royalty fees as follows: During the Exclusive Term and the Non-Exclusive Term the Company will pay a royalty equal to the royalty rate (the “Royalty Rate”), multiplied by Company’s “Net Sales”. As used herein, “Net Sales” means gross invoiced sales of Products, directly or indirectly to unrelated third parties, less (a) discounts (including cash discounts), and retroactive price reductions or allowances actually allowed or granted from the billed amount (collectively “Discounts”); (b) credits, rebates, and allowances actually granted upon claims, rejections or returns, including recalls (voluntary or otherwise) (collectively, “Credits”); (c) freight, postage, shipping and insurance charges; (d) taxes, duties or other governmental charges levied on or measured by the billing amount, when included in billing, as adjusted for rebates and refunds; and (e) provisions for uncollectible accounts determined in accordance with reasonable accounting methods, consistently applied. The Royalty Rate shall be: 6% of net sales up to $500,000 of net sales for each Agreement year; 4% of Net Sales from $500,000 up to $2,500,000 of Net Sales for each Agreement year; 2% of Net Sales from $2,500,000 up to $20,000,000 of Net Sales for each Agreement year; and 1% of Net Sales in excess of $20,000,000 of Net Sales for each Agreement year. In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows: Agreement Year Minimum Royalty to be Paid with Respect to Such Agreement Year 1 st nd $ - 3 rd th $ 50,000 5 th th th $ 75,000 8 th th $ 100,000 10 th $ 125,000 The Company incurred $85,704 and $85,837 of royalty expenses for the three months ended April 30, 2016 and 2015. Royalty expenses are included in general and administrative expenses on the condensed consolidated statement of operations. Agreements with Placement Agents and Finders (A) April 1, 2015 The Company entered into a fourth Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective April 1, 2015 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, the Company shall pay to Spartan a non-refundable monthly fee of $10,000 through October 1, 2015. The monthly fee shall survive any termination of the Agreement. Additionally, (i) if at least $4,000,000 is raised in the Financing, the Company shall pay to Spartan a non-refundable fee of $5,000 per month from November 1, 2015 through October 2017; and (ii) if at least $5,000,000 is raised in the Financing, the Company shall pay to Spartan a non-refundable fee of $5,000 per month from November 1, 2017 through October 2019. If $10,000,000 or more is raised in the Financing, the Company shall issue to Spartan shares of its common stock having an aggregate value of $5,000 (as determined by reference to the average volume weighted average trading price for the last five trading days of the immediately preceding month) on the first day of each month during the period from November 1, 2015 through October 1, 2019. The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants to purchase a number of shares of the Company’s common stock equal to 10% of the number of shares of common stock (and/or shares of common stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of common stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing. During the year ended January 31, 2016, the Company paid to Spartan a one-time engagement fee of $10,000. In connection with the Initial Closing, the Company agreed to pay an aggregate cash fee and non-accountable allowance of $157,300. The Company also granted warrants to purchase 179,259 shares of common stock at $0.675 per share. The warrants have a grant date fair value of $84,547 which is treated as a direct cost of the Financing and has been recorded as a reduction in additional paid in capital. Operating Lease In January 2015, the Company began a lease agreement for office space in East Rutherford, NJ. The lease is for a 51 month term expiring on March 31, 2019 with annual payments of $18,848. Total future minimum payments required under operating lease as of April 30, 2016 are as follows. For the Twelve Month Period Ending April 30, 2017 $ 18,848 2018 18,848 2019 17,277 $ 54,973

Subsequent Events

Subsequent Events	3 Months Ended
	Apr. 30, 2016
Subsequent Events [Abstract]
Subsequent Events	Note 12 - Subsequent Events On May 3, 2016, the Company granted 123,000 options to purchase common stock to employees and consultants. The options vest over a three year period with an exercise price of $0.60. On May 15, 2016, the Company entered into a consulting agreement for investor relations services. Pursuant to the agreement, the consultant will receive a monthly fee of $2,500 in addition to 250,000 shares of common stock subject to a twelve month vesting schedule. The Company has the option to issue the consultant an additional 50,000 shares of common stock upon the 18 month anniversary of the contract.

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2016
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for doubtful accounts, inventory obsolescence and the fair value of share-based payments. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.
Risks and Uncertainties	Risks and Uncertainties The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure. The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.
Cash	Cash The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at April 30, 2016 or January 31, 2016. The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of April 30, 2016 and January 31, 2016, the Company had reserves of $2,000.
Inventories	Inventories Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at April 30, 2016 and January 31, 2016: April 30, 2016 January 31, 2016 Finished goods $ 506,985 $ 252,752
Property and Equipment	Property and Equipment Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives. Asset lives for financial statement reporting of depreciation are: Machinery and equipment 2-7 years Furniture and fixtures 3-5 years Leasehold improvements 3-10 years
Fair Value of Financial Instruments	Fair Value of Financial Instruments For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short-term financial instruments approximates fair value due to the relatively short period to maturity for these instruments.
Stock Issuance Costs	Stock Issuance Costs Stock issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity and netted against proceeds. In the event the costs are in excess of the proceeds, the costs are recorded to expense. In the case of an aborted offering, all costs are expensed. Offering costs recorded to equity for the three months ended April 30, 2016 and 2015 were $0 and $0, respectively.
Research and Development	Research and Development Research and development is expensed as incurred. Research and development expenses for the three months ended April 30, 2016 and 2015 were $30,562 and $23,079, respectively.
Shipping and Handling Costs	Shipping and Handling Costs The Company classifies freight billed to customers as sales revenue and the related freight costs as general and administrative expenses.
Revenue Recognition	Revenue Recognition The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products. The Company meets these criteria upon shipment. Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows: Three Months Ended April 30, 2016 Three Months Ended April 30, 2015 Gross Sales $ 4,040,988 $ 3,428,864 Less: Slotting, Discounts, Allowances 117,011 192,374 Net Sales $ 3,923,977 $ 3,236,490
Cost of Sales	Cost of Sales Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.
Advertising	Advertising Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the three months ended April 30, 2016 and 2015 were $420,892 and $800,143, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “ Compensation – Stock Compensation” Equity Based Payments to Non-Employees The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the condensed consolidated statement of operations. Share-based payments issued to placement agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital. For the three months ended April 30, 2016 and 2015, share-based compensation amounted to $179,208 and $2,042, respectively. For the three months ended April 30, 2016, when computing fair value of share-based payments, the Company has considered the following variables: April 30, 2016 Risk-free interest rate 1.28% to 1.33 % Expected life of grants 2.5 years Expected volatility of underlying stock 178% to 179 % Dividends 0 % The expected option term is computed using the “simplified” method as permitted under the provisions of ASC 718-10-599. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. The expected stock price volatility for the Company’s stock options was determined by the historical volatilities for industry peers and used an average of those volatilities. Risk free interest rates were obtained from U.S. Treasury rates for the applicable periods.
Earnings (Loss) Per Share	Earnings (Loss) Per Share Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. The Company had the following potential common stock equivalents at April 30, 2016: Series A Preferred 3,466,667 Common stock warrants, exercise price range of $0.675-$2.50 4,964,734 Common stock options, exercise price of $0.39-$2.97 758,404 Total common stock equivalents 9,189,805 The Company had the following potential common stock equivalents at April 30, 2015: Common stock warrants, exercise price range of $1.00-$2.50 1,004,735 Common stock options, exercise price of $1.00-$2.97 496,404 Total common stock equivalents 1,501,139 Since the Company reflected a net loss during the three months ended April 30, 2016 and 2015, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented.
Income Taxes	Income Taxes Income taxes are provided in accordance with ASC No. 740, “ Accounting for Income Taxes Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company is no longer subject to tax examinations by tax authorities for years prior to 2012.
Reclassification	Reclassification Certain prior period amounts have been reclassified to conform to current period presentation.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In May 2014, the FASB issued a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The standard’s core principle (issued as ASU 2014-09 by the FASB), is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The new guidance must be adopted using either a full retrospective approach for all periods presented in the period of adoption or a modified retrospective approach. In August 2015, the FASB issued ASU No. 2015-14, which defers the effective date of ASU 2014-09 by one year, and would allow entities the option to early adopt the new revenue standard as of the original effective date. This ASU is effective for public reporting companies for interim and annual periods beginning after December 15, 2017. The Company is currently evaluating its adoption method and the impact of the standard on its condensed consolidated financial statements. In March 2015, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2015-03, “ Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs In July 2015, the FASB issued ASU No. 2015-11, “ Inventory (Topic 330): Simplifying the Measurement of Inventory” In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” In April 2016, the FASB issued ASU No. 2016-10, “ Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross verses Net)” In April 2016, the FASB issued ASU No. 2016-09, “ Compensation – Stock Compensation” Management does not believe that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial statements.

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Apr. 30, 2016
Accounting Policies [Abstract]
Schedule of Inventories	Inventory was comprised of the following at April 30, 2016 and January 31, 2016: April 30, 2016 January 31, 2016 Finished goods $ 506,985 $ 252,752
Schedule of Property and Equipment Estimated Useful Lives	Asset lives for financial statement reporting of depreciation are: Machinery and equipment 2-7 years Furniture and fixtures 3-5 years Leasehold improvements 3-10 years
Schedule of Expenses of Slotting Fees, Sales Discounts and Allowances are Accounted as Direct Reduction of Revenues	Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows: Three Months Ended April 30, 2016 Three Months Ended April 30, 2015 Gross Sales $ 4,040,988 $ 3,428,864 Less: Slotting, Discounts, Allowances 117,011 192,374 Net Sales $ 3,923,977 $ 3,236,490
Schedule of Fair Value of Share Based Payments	For the three months ended April 30, 2016, when computing fair value of share-based payments, the Company has considered the following variables: April 30, 2016 Risk-free interest rate 1.28% to 1.33 % Expected life of grants 2.5 years Expected volatility of underlying stock 178% to 179 % Dividends 0 %
Schedule of Common Stock Equivalents	The Company had the following potential common stock equivalents at April 30, 2016: Series A Preferred 3,466,667 Common stock warrants, exercise price range of $0.675-$2.50 4,964,734 Common stock options, exercise price of $0.39-$2.97 758,404 Total common stock equivalents 9,189,805 The Company had the following potential common stock equivalents at April 30, 2015: Common stock warrants, exercise price range of $1.00-$2.50 1,004,735 Common stock options, exercise price of $1.00-$2.97 496,404 Total common stock equivalents 1,501,139

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Apr. 30, 2016
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment on April 30, 2016 and January 31, 2016 are as follows: April 30, 2016 January 31, 2016 Machinery and Equipment $ 1,131,172 $ 1,112,522 Furniture and Fixtures 17,942 17,942 Leasehold Improvements 429,282 429,282 1,578,396 1,559,746 Less: Accumulated Depreciation 588,994 512,291 $ 989,402 $ 1,047,455

Loan and Security Agreement (Ta

Loan and Security Agreement (Tables)	3 Months Ended
	Apr. 30, 2016
Debt Disclosure [Abstract]
Schedule of Line of Credit	● Accounts Revolving Line of Credit: $ 2,150,000 ● Inventory Revolving Line of Credit: $ 350,000 ● Term Loan: $ 600,000

Convertible Note (Tables)

Convertible Note (Tables)	3 Months Ended
	Apr. 30, 2016
Debt Disclosure [Abstract]
Schedule of Future Maturities of Long Term Debt	Future maturities of long-term debt are as follows: For the Twelve Month Period Ending April 30, 2017 $ 4,341,421 2018 261,324 2019 120,000 2020 50,000 $ 4,772,745

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Tables)	3 Months Ended
	Apr. 30, 2016
Equity [Abstract]
Summary of Option Activity	The following is a summary of the Company’s option activity: Options Weighted Average Exercise Price Outstanding – January 31, 2016 496,404 $ 1.04 Exercisable – January 31, 2016 496,404 $ 1.04 Granted 262,000 $ 0.40 Exercised - $ - Forfeited/Cancelled - $ - Outstanding – April 30, 2016 758,404 $ 0.81 Exercisable – April 30, 2016 758,404 $ 0.81
Summary of Option Outstanding and Exercisable	Options Outstanding Options Exercisable Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.39 – 2.97 758,404 2.69 years $ 0.81 758,404 $ 0.81
Schedule of Warrants Activity	The following is a summary of the Company’s warrant activity: Warrants Weighted Average Exercise Price Outstanding – January 31, 2016 4,964,734 $ 0.80 Exercisable – January 31, 2016 4,964,734 $ 0.80 Granted - $ - Exercised - $ - Forfeited/Cancelled - $ - Outstanding – April 30, 2016 4,964,734 $ 0.80 Exercisable – April 30, 2016 4,964,734 $ 0.80
Schedule of Warrants Outstanding and Exercisable	Warrants Outstanding Warrants Exercisable Range of Exercise Price Number Outstanding Weighted Average Remaining Contractual Life (in years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price $ 0.68-$2.50 4,964,734 3.86 years $ 0.80 4,964,734 $ 0.80

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Apr. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Schedule of Royalty Minimum Payment by Preceding Agreement Year	In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows: Agreement Year Minimum Royalty to be Paid with Respect to Such Agreement Year 1 st nd $ - 3 rd th $ 50,000 5 th th th $ 75,000 8 th th $ 100,000 10 th $ 125,000
Schedule of Future Minimum Payments Under Operating Leases	Total future minimum payments required under operating lease as of April 30, 2016 are as follows. For the Twelve Month Period Ending April 30, 2017 $ 18,848 2018 18,848 2019 17,277 $ 54,973

Nature of Operations and Basi25

Nature of Operations and Basis of Presentation (Details Narrative) - USD ($)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015	Jan. 31, 2016	Jan. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss available to common shareholders	$ 290,628	$ 1,094,556
Cash	502,459	$ 399,967	$ 587,422	$ 854,995
Working capital	$ 85,338

Summary of Significant Accoun26

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015	Jan. 31, 2016
Accounting Policies [Abstract]
Cash equivalents
Accounts receivable reserves	$ 2,000		$ 2,000
Stock offering cost	0	$ 0
Research and development expense	30,562	23,079
Advertising expenses	420,892	800,143
Share based compensation	$ 179,208	$ 2,042

Summary of Significant Accoun27

Summary of Significant Accounting Policies - Schedule of Inventories (Details) - USD ($)	Apr. 30, 2016	Jan. 31, 2016
Accounting Policies [Abstract]
Finished goods	$ 506,985	$ 252,752

Summary of Significant Accoun28

Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details)	3 Months Ended
	Apr. 30, 2016
Minimum [Member] | Machinery And Equipment [Member]
Property and equipment estimated useful lives	2 years
Minimum [Member] | Furniture And Fixtures [Member]
Property and equipment estimated useful lives	3 years
Minimum [Member] | Leasehold Improvements [Member]
Property and equipment estimated useful lives	3 years
Maximum [Member] | Machinery And Equipment [Member]
Property and equipment estimated useful lives	7 years
Maximum [Member] | Furniture And Fixtures [Member]
Property and equipment estimated useful lives	5 years
Maximum [Member] | Leasehold Improvements [Member]
Property and equipment estimated useful lives	10 years

Summary of Significant Accoun29

Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees, Sales Discounts and Allowances are Accounted as Direct Reduction of Revenues (Details) - USD ($)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Accounting Policies [Abstract]
Gross Sales	$ 4,040,988	$ 3,428,864
Less: Slotting, Discounts, Allowances	117,011	192,374
Net Sales	$ 3,923,977	$ 3,236,490

Summary of Significant Accoun30

Summary of Significant Accounting Policies - Schedule of Fair Value of Share Based Payments (Details)	3 Months Ended
	Apr. 30, 2016
Accounting Policies [Abstract]
Risk-free interest rate, minimum	1.28%
Risk-free interest rate, maximum	1.33%
Expected life of grants	2 years 6 months
Expected volatility of underlying stock, minimum	178.00%
Expected volatility of underlying stock, maximum	179.00%
Dividends	0.00%

Summary of Significant Accoun31

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) - shares	Apr. 30, 2016	Apr. 30, 2015
Accounting Policies [Abstract]
Series A Preferred	3,466,667
Common stock warrants, exercise price	4,964,734	1,004,735
Common stock options, exercise price	758,404	496,404
Total common stock equivalents	9,189,805	1,501,139

Summary of Significant Accoun32

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) (Parenthetical) - $ / shares	Apr. 30, 2016	Jan. 31, 2016	Apr. 30, 2015
Common stock options, exercise price	$ 0.81	$ 1.04
Minimum [Member]
Common stock warrants, exercise price	0.675		$ 1
Common stock options, exercise price	0.39		1
Maximum [Member]
Common stock warrants, exercise price	2.50		2.50
Common stock options, exercise price	$ 2.97		$ 2.97

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 76,703	$ 67,200

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)	Apr. 30, 2016	Jan. 31, 2016
Property, Plant and Equipment [Abstract]
Machinery and Equipment	$ 1,131,172	$ 1,112,522
Furniture and Fixtures	17,942	17,942
Leasehold Improvements	429,282	429,282
Property Plant And Equipment, Gross	1,578,396	1,559,746
Less: Accumulated Depreciation	588,994	512,291
Property, plant and equipment, net	$ 989,402	$ 1,047,455

Investment in Meatball Obsess35

Investment in Meatball Obsession, LLC (Details Narrative) - Meatball Obsession, LLC [Member] - USD ($)	Dec. 31, 2011	Apr. 30, 2016	Jan. 31, 2016
Percentage of equity interest acquired in business combination	34.62%
Investment in business combination	$ 27,032
Reduction in investment due to losses in affiliates	$ 0
Ownership interest percentage		12.00%	12.00%

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Oct. 29, 2015	May 31, 2015	Apr. 30, 2016	Apr. 30, 2015	Jan. 31, 2016
Due from manufacturer - related party			$ 2,197,051		$ 2,248,781
Due from related party
Note mature date	Dec. 19, 2016	Jul. 22, 2016
Note principal balance amount			$ 125,000
Meatball Obsession, LLC [Member]
Revenue from related parties			10,102	$ 25,408
Due from related party			3,296		$ 6,512
WWS, Inc [Member]
Commission expense			12,000	12,000
CEO [Member]
Proceeds from notes payable with related party			$ 125,000
Note bears interest rate per annum			4.00%
Note mature date			Dec. 31, 2016
Joseph Epstein Foods [Member]
Minimum purchase of product each month amount			$ 933,000
Percentage of shortfall each month			12.00%
Percentage of overage of gross margin each month			12.00%
Purchased inventory from manufacturer			$ 2,843,012	2,425,621
Administrative expenses and salary expenses			$ 6,000	$ 6,000

Promissory Notes (Details Narra

Promissory Notes (Details Narrative) - USD ($)	Oct. 31, 2015	Oct. 29, 2015	Jan. 31, 2016	Nov. 30, 2015	May 31, 2015	Apr. 30, 2016	Apr. 30, 2015
Debt maturity date		Dec. 19, 2016			Jul. 22, 2016
Repayment of outstanding balace						$ 79,490
Outstanding balance on note			$ 336,575			257,085
Private Placement [Member]
Percentage of prepay note				10.00%
Repayment of outstanding balace				$ 173,373
Promissory Note Agreement [Member] | Third Party [Member]
Note principal balance	$ 358,832
Debt interest rate	10.00%
Debt maturity date	Oct. 31, 2017
Percentage of prepay note	10.00%
Outstanding balance on note			239,459			191,082
Promissory Note Agreement One [Member] | Third Party [Member]
Note principal balance			$ 116,003
Debt interest rate			6.00%
Debt maturity date			Oct. 31, 2016
Outstanding balance on note			$ 97,116			$ 66,003

Loan and Security Agreement (De

Loan and Security Agreement (Details Narrative) - USD ($)	Sep. 03, 2014	Apr. 30, 2016	Jan. 31, 2016
Line of credit		$ 1,423,165	$ 933,001
Line of credit debt discount		17,495	26,620
Loan and Security Agreement [Member] | Entrepreneur Growth Capital LLC [Member]
Line of credit		1,423,165	933,001
Line of credit debt discount		17,495	26,620
Line of credit aggregate value	$ 3,100,000
Percentage of accounts revolving line of credit maximum	85.00%
Percentage of finished goods amount	50.00%
Percentage of raw material amount	20.00%
Line of credit interest rate description	The revolving interest rates is equal to the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus (a) 2.5% on loans and advances made against eligible accounts and (b) 4.0% on loans made against eligible inventory. The term loan bears interest at a rate of the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0%. The initial term of the facility is for a period of two years and will automatically renew for an additional one year period. The Company was required to pay a one-time, up-front facility fee equal to 2.25% of the total $3,100,000 facility and pays an annualized maintenance fee equal to 3% of the total facility. In the event of default, the Company shall pay 10% above the stated rates of interest per the Agreement. The drawdowns are secured by all of the assets of the Company.
Line of credit annual facility percentage	2.25%
Line of credit default stated rates of interest	10.00%
Secured Promissory Note [Member] | Entrepreneur Growth Capital LLC [Member]
Term loan outstanding		$ 410,000	$ 440,000
Secured Promissory Note [Member] | Entrepreneur Growth Capital LLC [Member]
Line of credit aggregate value	$ 600,000
Line of credit interest rate description	The EGC Note bears interest at the prime rate plus 4.0% and is payable monthly, in arrears. In the event of default, the Company shall pay 10% above the stated rates of interest per the Loan and Security Agreement.
Line of credit default stated rates of interest	10.00%
Term of loan	5 years
Repayment of secured debt, monthly installment basis	$ 10,000
Note payable, during period	60 months

Loan and Security Agreement - S

Loan and Security Agreement - Schedule of Line of Credit (Details)	Sep. 03, 2014USD ($)
Accounts Revolving Line of Credit [Member]
Line of credit facility	$ 2,150,000
Inventory Revolving Line of Credit [Member]
Line of credit facility	350,000
Term Loan [Member]
Line of credit facility	$ 600,000

Convertible Note (Details Narra

Convertible Note (Details Narrative) - USD ($)	Oct. 29, 2015	Dec. 19, 2014	Nov. 30, 2015	May 31, 2015	Apr. 30, 2015	Apr. 30, 2016	Apr. 30, 2015	Jan. 31, 2016
Common stock price per shares								$ 0.675
Debt discount						$ 9,125	$ 118,552
Unamortized debt discount						0		$ 0
Debt maturity date	Dec. 19, 2016			Jul. 22, 2016
Sale of stock during period	230,000		10,200
Sale of stock price per share	$ 0.65
Sale of stock during period, value	$ 149,500
Amendment fee	170,500					170,500
Accrued interest	220,000
Increased in outstanding principal of debt	220,000
Debt extinguishment						2,000,000
Unamortized debt discount						190,483
Debt issuance cost	$ 19,106					19,106
Loss on debt extinguishment						380,089
Remaining debt discount						190,483
Convertible note payable						2,540,000		$ 2,540,000
Manatuck Hill Partners, LLC [Member]
Debt discount						$ 498,350
Manatuck Purchase Agreement [Member] | Manatuck Hill Partners, LLC [Member]
Convertible debenture		$ 2,000,000
Convertible debt, interest rate percentage		14.00%
Debt maturity month year		February 2,016
Number of restricted common stock granted, shares		200,000			30,000
Debt maturity extended month year					May 2,016
Common stock price per shares					$ 1.32		$ 1.32
Debt discount					$ 39,600

Convertible Note - Schedule of

Convertible Note - Schedule of Future Maturities of Long Term Debt (Details)	Apr. 30, 2016USD ($)
Debt Disclosure [Abstract]
2,017	$ 4,341,421
2,018	261,324
2,019	120,000
2,020	50,000
Future maturities of long term debt total	$ 4,772,745

Concentrations (Details Narrati

Concentrations (Details Narrative)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Sales Revenue [Member] | Customer A [Member]
Concentrations of risk percentage	14.00%	20.00%
Sales Revenue [Member] | Customer B [Member]
Concentrations of risk percentage	13.00%	16.00%
Sales Revenue [Member] | Customer C [Member]
Concentrations of risk percentage	12.00%	15.00%
Sales Revenue [Member] | Customer D [Member]
Concentrations of risk percentage	11.00%	11.00%
Accounts Receivable [Member] | Customer A [Member]
Concentrations of risk percentage	16.00%	14.00%
Accounts Receivable [Member] | Customer B [Member]
Concentrations of risk percentage	8.00%	11.00%
Accounts Receivable [Member] | Customer C [Member]
Concentrations of risk percentage	14.00%	23.00%
Accounts Receivable [Member] | Customer D [Member]
Concentrations of risk percentage	25.00%	7.00%
Cost Of Sales [Member] | Vendor One [Member]
Concentrations of risk percentage	98.00%	95.00%

Stockholders' Equity (Deficit43

Stockholders' Equity (Deficit) (Details Narrative)	Oct. 29, 2015USD ($)shares	Oct. 29, 2015shares	May 28, 2015USD ($)$ / sharesshares	Apr. 30, 2016USD ($)$ / sharesshares	Jan. 31, 2016USD ($)$ / sharesshares	Nov. 30, 2015USD ($)Accreditedshares	Jun. 30, 2015USD ($)	May 31, 2015USD ($)Integer$ / sharesshares	Apr. 30, 2016USD ($)$ / sharesshares	Apr. 30, 2015USD ($)
Preferred stock, shares authorized | shares				19,880,000	19,880,000				19,880,000
Preferred stock, par value | $ / shares				$ 0.00001	$ 0.00001				$ 0.00001
Shares issued exercise price per share | $ / shares					$ 0.675
Number of warrants granted to purchase of shares of common stock | shares						1,511,112
Number of directors | Integer								6
Convertible note agreements maturity date		Dec. 19, 2016						Jul. 22, 2016
Proceeds from convertible note								$ 650,000
Additional proceeds from convertible note							$ 560,000
Warrants grant date fair value					$ 84,547
Number of accredited investors | Accredited						11
Number of shares issued | shares		230,000				10,200
Gross proceeds from issuance of stock						$ 1,020,000
Stock issuance costs						132,600
Net proceeds from issuance of stock						887,400
Debt issuance cost						$ 86,000
Repurchase of treasury stock, shares | shares	230,000
Repurchase of treasury stock	$ 149,500
Total intrinsic value of options outstanding and exercisable				$ 25,000					$ 25,000	$ 87,733
Total intrinsic value of warrants outstanding and exercisable				$ 0					$ 0	$ 88,925
Shareholders [Member]
Shares issued exercise price per share | $ / shares								$ 0.675
Number of warrants granted to purchase of shares of common stock | shares								1,481,481
Placement Agent [Member]
Shares issued exercise price per share | $ / shares								$ 0.675
Number of warrants granted to purchase of shares of common stock | shares								179,259
Warrants grant date fair value								$ 84,547
Employees [Member]
Number of stock issued for employees services , shares | shares									179,592
Number of stock issued for employees services									$ 92,000
Investors [Member]
Number of warrants granted to purchase of shares of common stock | shares				2,510,001					2,510,001
Warrants term				5 years
Warrants exercise price per share | $ / shares				$ 1.50					$ 1.50
Series A Preferred Stock [Member]
Preferred stock, shares authorized | shares			120,000
Preferred stock, par value | $ / shares			$ 0.00001
Preferred stock adjusted for stock dividends			$ 100
Percentage of preferred stock dividends rate			8.00%
Preferred stock liquidation preference per share | $ / shares			$ 0.675
Conversion of stock dividing par value | $ / shares			$ 0.675
Common stock exercisable period			5 years
Number of warrants granted to purchase of shares of common stock | shares					162,963
Notes principal amount					$ 116,003
Issuance of common stock shares for cashless exercise of warrants | shares					1,100
Warrant [Member]
Conversion of stock dividing par value | $ / shares			$ 0.675
Shares issued exercise price per share | $ / shares			$ 1
Series A Preferred Stockholders [Member]
Number common stock shares issued for dividends in arrears | shares									268,395
Number common stock issued for dividends in arrears									$ 131,513

Stockholders' Equity (Deficit44

Stockholders' Equity (Deficit) - Summary of Option Activity (Details)	3 Months Ended
	Apr. 30, 2016$ / sharesshares
Equity [Abstract]
Options Outstanding, Beginning balance | shares	496,404
Options Exercisable, Beginning balance | shares	496,404
Options, Granted | shares	262,000
Options, Exercised | shares
Options, Forfeited/Cancelled | shares
Options Outstanding, Ending balance | shares	758,404
Options Exercisable, Ending balance | shares	758,404
Options Outstanding, Weighted Average Exercise Price, Beginning balance | $ / shares	$ 1.04
Options Exercisable, Weighted Average Exercise Price, Beginning balance | $ / shares	1.04
Weighted Average Exercise Price, Granted | $ / shares	$ 0.40
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Options Outstanding, Weighted Average Exercise Price, Ending balance | $ / shares	$ 0.81
Options Exercisable, Weighted Average Exercise Price, Ending balance | $ / shares	$ 0.81

Stockholders' Equity (Deficit45

Stockholders' Equity (Deficit) - Summary of Option Outstanding and Exercisable (Details) - Range Of Exercise Price One [Member]	3 Months Ended
	Apr. 30, 2016$ / sharesshares
Range of exercise price lower range limit	$ 0.39
Range of exercise price upper range limit	$ 2.97
Number of Options Outstanding | shares	758,404
Weighted Average Remaining Contractual Life (in years), Options Outstanding	2 years 8 months 9 days
Weighted Average Exercise Price, Options Outstanding	$ 0.81
Number of Options Exercisable | shares	758,404
Weighted Average Exercise Price, Options Exercisable	$ 0.81

Stockholders' Equity (Deficit46

Stockholders' Equity (Deficit) - Schedule of Warrants Activity (Details) - Warrant [Member]	3 Months Ended
	Apr. 30, 2016$ / sharesshares
Warrants Outstanding, Beginning balance | shares	4,964,734
Warrants Exercisable, Beginning balance | shares	4,964,734
Warrants, Granted | shares
Warrants, Exercised | shares
Warrants, Forfeited/Cancelled | shares
Warrants Outstanding, Ending balance | shares	4,964,734
Warrants Exercisable, Ending balance | shares	4,964,734
Warrants Outstanding, Weighted Average Exercise Price, Beginning balance | $ / shares	$ 0.80
Warrants Exercisable, Weighted Average Exercise Price, Beginning balance | $ / shares	$ 0.80
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited/Cancelled | $ / shares
Warrants Outstanding, Weighted Average Exercise Price, Ending balance | $ / shares	$ 0.80
Warrants Exercisable, Weighted Average Exercise Price, Ending balance | $ / shares	$ 0.80

Stockholders' Equity (Deficit47

Stockholders' Equity (Deficit) - Schedule of Warrants Outstanding and Exercisable (Details) - Warrant [Member] - $ / shares	3 Months Ended
	Apr. 30, 2016	Jan. 31, 2016
Range of Exercise Price, lower limit	$ 0.68
Range of Exercise Price, upper limit	$ 2.50
Number of Warrants Outstanding	4,964,734	4,964,734
Weighted Average Remaining Contractual Life (in Years)	3 years 10 months 10 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.80
Number of Warrants Exercisable	4,964,734	4,964,734
Weighted Average Exercise Price, Warrants Exercisable	$ 0.80	$ 0.80

Commitments and Contingencies48

Commitments and Contingencies (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 30, 2016	Apr. 30, 2015	Jan. 31, 2016
Royalty expenses	$ 85,704	$ 85,837
Warrants issued to investors			179,259
Shares issued exercise price per share			$ 0.675
Warrants grant date fair value			$ 84,547
Operating lease annual payments	$ 54,973
Spartan Capital Securities, LLC [Member]
Percentage of fee equal to aggregate gross proceeds	10.00%
Percentage of fees equal to aggregate gross proceeds for expenses	3.00%
Percentage of common stock issuable	10.00%
One-time engagement fee			10,000
Cash fee and non-accountable allowance			$ 157,300
Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member]
Nonrefundable monthly fee amount	$ 10,000
Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member] | March 31, 2019 [Member]
Operating lease expiration term	51 months
Lease agreement expire date	Mar. 31, 2019
Operating lease annual payments	$ 18,848
Minimum [Member] | Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member]
Nonrefundable monthly fee amount	$ 5,000
Nonrefundable monthly fee term	November 1, 2015 through October 2017
Aggregate gross proceeds fee	$ 4,000,000
Maximum [Member] | Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member]
Nonrefundable monthly fee amount	$ 5,000
Nonrefundable monthly fee term	November 1, 2017 through October 2019
Aggregate gross proceeds fee	$ 5,000,000
Year 1 [Member]
Percentage of royalty on net sales	6.00%
Royalty revenue	$ 500,000
Year 2 [Member]
Percentage of royalty on net sales	4.00%
Year 2 [Member] | Minimum [Member]
Royalty revenue	$ 500,000
Year 2 [Member] | Maximum [Member]
Royalty revenue	$ 2,500,000
Year 3 [Member]
Percentage of royalty on net sales	2.00%
Year 3 [Member] | Minimum [Member]
Royalty revenue	$ 2,500,000
Year 3 [Member] | Maximum [Member]
Royalty revenue	$ 20,000,000
Year 4 [Member]
Percentage of royalty on net sales	1.00%
Royalty revenue	$ 20,000,000
$10,000,000 or More Raised Financing [Member] | Spartan Capital Securities, LLC [Member] | Advisory Agreement [Member]
Nonrefundable monthly fee amount	$ 5,000
Nonrefundable monthly fee term	November 1, 2015 through October 1, 2019
Aggregate gross proceeds fee	$ 10,000,000

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details) - USD ($)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Minimum Royalty to be Paid	$ 85,704	$ 85,837
Agreement Year 1st and 2nd [Member]
Minimum Royalty to be Paid
Agreement Year 3rd and 4th [Member]
Minimum Royalty to be Paid	$ 50,000
Agreement Year 5th, 6th and 7th [Member]
Minimum Royalty to be Paid	75,000
Agreement Year 8th and 9th [Member]
Minimum Royalty to be Paid	100,000
Agreement Year 10th and thereafter [Member]
Minimum Royalty to be Paid	$ 125,000

Commitments and Contingencies50

Commitments and Contingencies - Schedule of Future Minimum Payments Under Operating Leases (Details)	Apr. 30, 2016USD ($)
Commitments and Contingencies Disclosure [Abstract]
2,017	$ 18,848
2,018	18,848
2,019	17,277
Total	$ 54,973

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent Event [Member] - USD ($)	May 15, 2016	May 03, 2016
Employees And Consultants [Member]
Number of stock options to purchase of common stock		123,000
Stock option vested period		3 years
Stock options exercise price per share		$ 0.60
Investor Relations Services [Member] | Consulting Agreement [Member]
Consultant monthly fee	$ 2,500
Number of common stock vested share	250,000
Investor Relations Services [Member] | Consulting Agreement [Member] | 18 Month Anniversary [Member]
Number of common stock vested share	50,000